MerckVaccines.com
Storage and Handling
 
  Product Features
  Indications
  Efficacy
  Safety and Tolerability
  Dosage and Administration
Storage and Handling
  Prescribing Information
  Patient Product Information
  Select Safety Information
  Important Recommendations
  Reimbursement Information
  Complimentary Resources
  What Your Patients See
 
Select Another Product












 
General tips
  • If you have questions about the condition of the vaccine at the time of delivery, you should immediately place vaccine in recommended storage; and call the Merck Vaccine Customer Center at 1-877-VAX-MERCK (1-877-829-6372), or call the CDC at 1-800-CDC-INFO (1-800-232-4636).
  • Rotate stock so that the shortest-dated vaccine is used first.1
  • Ensure that the refrigerator is plugged into an outlet in a protected area where it cannot be disconnected accidentally.1
  • Record refrigerator and freezer temperatures twice a day in a temperature log.1
  • All vaccines must be discarded after the expiration date; expired or damaged Vaccines for Children (VFC) vaccines must be returned to your State Immunization Program.
  • For general questions concerning the proper storage and handling of Merck vaccines, please contact the Merck Vaccine Customer Center at 1-800-MERCK-90 (1-800-637-2590), Monday through Friday, 8:00 am–7:00 pm ET.
  • Before administering RotaTeq, please read the Prescribing Information and Patient Product Information.

    1. Centers for Disease Control and Prevention. Vaccine storage and handling (Appendix C). In: Atkinson W, Hamborsky J, McIntyre L, Wolfe S, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 10th ed. Washington, DC: Public Health Foundation; 2007:C1–C20.

Select safety information

RotaTeq should not be administered to infants with a demonstrated history of hypersensitivity to the vaccine or any component of the vaccine.

No safety or efficacy data are available for the administration of RotaTeq to infants who are potentially immunocompromised or to infants with a history of gastrointestinal disorders.

Caution is advised when considering whether to administer RotaTeq to individuals with immunodeficient contacts.

In clinical trials, the most common adverse events included diarrhea, vomiting, irritability, otitis media, nasopharyngitis, and bronchospasm.

In post-marketing experience, cases of intussusception and Kawasaki disease have been reported in infants who have received RotaTeq.

RotaTeq may not protect all vaccine recipients against rotavirus.

Before administering RotaTeq, please read the Prescribing Information and Patient Product Information.

View storage and handling requirements for all Merck vaccines.